Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Canntab Therapeutics Ltd C.PILL

Alternate Symbol(s):  CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and... see more

CSE:PILL - Post Discussion

View:
Post by Druchii on Nov 11, 2021 9:44am

Huge News

This news is huge - amazing job Canntab!

Company has low market cap and is the only producer with Cannabis 3.0.

Seems like a multi-bagger from here!!
Comment by Eppy on Nov 11, 2021 5:04pm
I agree that it is huge news.  I have to admit though, I am a little disappointed that the share price only went up  10 cents.  I am sure more news is coming over the next few weeks and hopefully investors will find this company worth buying shares in.  It certainly is undervalued at this price.  I can hardly wait until the new year when sales should start to move the ...more  
Comment by Druchii on Nov 11, 2021 6:11pm
I hear you, I was expecting much more as well. Took the opportunity to buy more.  Not sure why anyone would sell on this news for a few pennies.  This was the announcement all shareholders should have been waiting for.